Synaptogenix Has Been Granted U.S. Patent Number 12,016,837 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegenerative Diseases (Including Alzheimer's Disease)"
Synaptogenix Has Been Granted U.S. Patent Number 12,016,837 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegenerative Diseases (Including Alzheimer's Disease)"
Synaptogenix获得了美国专利编号12,016,837，标题为"环丙烯酸不饱和脂肪酸的卤代酯在神经退行性疾病（包括阿尔茨海默病）治疗中的应用"
Synaptogenix Has Been Granted U.S. Patent Number 12,016,837 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegenerative Diseases (Including Alzheimer's Disease)"
Synaptogenix已获得美国专利编号12,016,837，标题为“环丙烷烯基不饱和脂肪酸的卤代酯在神经退行性疾病（包括阿尔茨海默病）治疗中的应用”。